Cancer stem cell targeted agents: therapeutic approaches and consequences

Area of Science:

• Oncology
• Stem Cell Biology

Background:

• Advancements in stem cell biology and identification of tumor-initiating cancer stem cells (CSCs) have revitalized interest in CSCs as therapeutic targets.
• CSCs possess self-renewal and proliferative capabilities similar to normal stem cells, but also unique, cancer-specific features exploitable for treatment.

Purpose of the Study:

• To review general and tumor-specific cancer stem cell targets.
• To describe inhibitors of these targets for potential clinical applications.

Main Methods:

• Literature review of cancer stem cell biology.
• Identification and analysis of therapeutic targets and existing inhibitors.

Main Results:

• CSCs exhibit distinct characteristics that make them viable therapeutic targets.
• Existing anticancer agents and experimental therapeutics show potential in inhibiting CSC maintenance pathways.

Conclusions:

• Targeting CSCs offers a promising strategy for cancer therapy.
• Inhibitors of CSC targets can be integrated into clinical protocols alongside conventional chemotherapy for improved debulking and eradication.